Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation

Clinical trial NCT00464256 · COMPLETED

Trial details

NCT number: NCT00464256
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2004-04-01
Primary completion: 2004-11-01
Enrollment: 533

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.